Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
Johns Hopkins University · with American Heart Association, National Institute on Minority Health and Health Disparities (NIMHD) · NCT07075588
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- June 25, 2026
- Record last updated
- June 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
iTHRIVE intervention is a 2-arm randomized controlled trial testing the effects of digital FARMacy, personalized dietitian coaching with produce prescriptions, and home blood pressure measurement in 100 hypertensive adults living in high food priority areas in counties in Maryland.
Being studied: iTHRIVE intervention; Active comparator
Conditions: Hypertension; Hypertension Complicated With Type 2 Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 21-70 years
- Self-identify as Black/African American or Hispanic/Latino
- Have Stage 2 CKM defined as:
- Systolic BP ≥130mmHg (measured at screening) AND at least one of:
- Hypertension (ICD-10: I10-I16)
- Prediabetes (HbA1c 5.7-6.4%) or Type 2 Diabetes (HbA1c ≥6.5%)
- Stage 3 chronic kidney disease (CKD) (eGFR 30-59 mL/min/1.73m²)
- Live in census tracts identified by the Montgomery/ Prince George's/Baltimore City County Departments of Planning as HFPA:
- Healthy Food Availability Index score is low (0-9.5),
- Median household income ≤185% of Federal Poverty Level
- 30% of households have no vehicle,
- Distance to supermarket >1/4 mile. 5. Have refrigeration, food preparation appliances (microwave, stove), and cell phones for the App
Exclusion Criteria
- Age \<21 years
- Diagnosis of end-stage renal disease (ESRD), dialysis
- Serious medical condition that either limits life expectancy or requires active management (e.g., cancer)
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥ 30 days)
- Patients with cognitive impairment or other condition preventing their participation in the intervention
- Pregnant, breastfeeding, or planning pregnancy
- Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation) or another clinical trial that could interfere with the study protocol
- Planning to move out of the geographic area in 12 months
Recruiting US locations
Johns Hopkins Community Physicians
Baltimore, MD 21205
Site contact: Margaret Utibe · 410-873-7993 · thrive-fim@jh.edu
Study contacts (from the official record)
- Oluwabunmi Ogungbe, PhD, MPH, RN · 410-614-1519 · oogungb3@jh.edu
- Yvonne Commodore-Mensah, PhD, MHS, RN · 410614159 · ycommod1@jhmi.edu
Similar studies in Maryland
All diabetes studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersOvernight stay mentioned
Urinary Vitamin C Loss in Diabetic Subjects
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
Vasopressin and Pain Perception in the Brain
University of Maryland, Baltimore
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Silver Spring, MD + 55 other US sites
- Eligibility basics
- Ages 18–79